Company Information

CIN
Status
Date of Incorporation
26 July 2010
State / ROC
Mumbai / ROC Mumbai
Industry
Sub Category
Non-govt company
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
41,129,960
Authorised Capital
60,000,000

Patents

Pharmaceutical Formulation Of Tadalafil And Process For The Preparation Thereof

An improved pharmaceutical formulation of tadalafil i.e., (6R-trans)-6-(l,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino-[1,2":l,6] pyrido[3,4-b]indole-l,4-dione" or a pharmaceutically acceptable salt thereof and process for the preparing thereof are disclosed.

Stable Pharmaceutical Compositions Of Ezetimibe In Combination With Hmg Coa Reductase Inhibitors

The present invention relates to a pharmaceutical composition comprising simvastatin and ezetimibe and an organic acidifiers wherein particularly citric acid and ascorbic acid are omitted.

Pharmaceutical Formulation Of Dabigatran Etexile Methyl Sulfonate And Process For The Preparation Thereof

The present invention relates to pharmaceutical composition comprising Dabigatranetexile methyl sulfonate pellets without talc and Organic acid pellets.

A Solid Oral Composition Of Teriflunomide

A solid oral composition of teriflunomide comprising (a) 1 % to 30 % w/w of teriflunomide; (b) less than 0.5% w/w of an alkalinizing agent; and (d) one or more pharmaceutical excipient(s); wherein the composition is stable at 40°C and about 75% relative humidity for about 12 months & the process of its prepar...

An Immediate Release Composition Of Sitagliptin Hydrochloride

An immediate release composition comprising Sitagliptin hydrochloride and/or solvate and one or more pharmaceutical excipient(s), wherein the composition is prepared by wet granulation.

Reconstitutable, Single Use Antidiabetic Compositions

The present invention relates to reconstitutable, single use antidiabetic compositions which provide a single use composition comprising a) metformin or pharmaceutically acceptable salt as an extended release composition, b) optionally one or more antidiabetic agent(s) and optionally pharmaceutical acceptable excip...

A Tablet Composition Of Mirabegron

A controlled release pharmaceutical composition for oral administration comprising a therapeutically effective amount of mirabegron or a pharmaceutically acceptable salt thereof, as an active ingredient, a hydrogel-forming polymer, as release controlling polymer, a colloidal agent, as a diluent and a pharmaceutical...

“Film Coated Tablet Of Bempedoic Acid”

ABSTRACT FILM COATED TABLET OF BEMPEDOIC ACID The present invention relates to a pharmaceutical formulation comprising: a) bempedoic acid or pharmaceutically acceptable salts thereof admixed with monometal silicates, magnesium citrate, talc or starch and lubricants, optionally one or more pharmaceutically acceptab...

Trademarks

V Ensure

[Class : 40] Treatment Of Materials

V Ensure

[Class : 42] Scientific And Technological Services And Research And Design Relating Thereto; Industrial Analysis And Research Services For Pharmaceutical